About Aquila BioMedical
Aquila BioMedical is a company based in Edinburgh (United Kingdom) founded in 2011 was acquired by Concept Life Sciences in October 2017.. The company has 489 employees as of January 31, 2022. Aquila BioMedical offers products and services including Integrated Drug Discovery, Chemistry Services, and Biology Services. Aquila BioMedical operates in a competitive market with competitors including Gubra, Tigermed, BioQual, Gentronix and Shanghai Semero Biotechnology, among others.
- Headquarter Edinburgh, United Kingdom
- Employees 489 as on 31 Jan, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Malvern Panalytical Limited
- Date of Incorporation 11 Aug, 1971
- Jurisdiction MALVERN, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$940.27 K (USD), Grant
May 01, 2020
-
Investors
European Union
& 1 more
-
Employee Count
489
as on Jan 31, 2022
-
Acquired by
Concept Life Sciences
(Oct 30, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aquila BioMedical
Aquila BioMedical offers a comprehensive portfolio of products and services, including Integrated Drug Discovery, Chemistry Services, and Biology Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Comprehensive platform for drug discovery from validation to optimization
Synthetic and medicinal chemistry for pharmaceutical research
Assay development and cell-based testing for drug efficacy
Funding Insights of Aquila BioMedical
- Total Funding Total Funding
- Total Rounds 2
- Last Round Grant — $940,272
- First Round First Round
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2020 | Amount | Grant - Aquila BioMedical | Valuation |
investors |
|
| Jan, 2016 | Amount | Grant - Aquila BioMedical | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Aquila BioMedical
Aquila BioMedical has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include European Union and Concept Life Sciences. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location | |
|
International laboratory testing and consultancy in life sciences are offered.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Aquila BioMedical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Aquila BioMedical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aquila Biomedical Comparisons
Competitors of Aquila BioMedical
Aquila BioMedical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gubra, Tigermed, BioQual, Gentronix and Shanghai Semero Biotechnology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Preclinical CRO services for NAFLD/NASH, diabetes, and obesity are provided.
|
|
| domain | founded_year | HQ Location |
Drug development and preclinical services are provided by Tigermed.
|
|
| domain | founded_year | HQ Location |
Contract research on infectious disease models is conducted.
|
|
| domain | founded_year | HQ Location |
In-vitro and in-vivo genetic toxicology screening services are provided.
|
|
| domain | founded_year | HQ Location |
Diversified preclinical services for brain-related disorders are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Aquila BioMedical
When was Aquila BioMedical founded?
Aquila BioMedical was founded in 2011 and raised its 1st funding round 5 years after it was founded.
Where is Aquila BioMedical located?
Aquila BioMedical is headquartered in Edinburgh, United Kingdom. It is registered at Edinburgh, Scotland, United Kingdom.
How many employees does Aquila BioMedical have?
As of Jan 31, 2022, the latest employee count at Aquila BioMedical is 489.
What does Aquila BioMedical do?
Aquila BioMedical was established in 2011 in Edinburgh, United Kingdom, as a preclinical contract research organization. Focus is placed on immunology, regeneration, neuroscience, and histology, with applications to multiple sclerosis, autoimmune diseases, inflammation, and pain. In-vitro and in-vivo proof-of-concept studies are conducted across these therapeutic areas to support research in the biotechnology and pharmaceutical sectors.
Who are the top competitors of Aquila BioMedical?
What products or services does Aquila BioMedical offer?
Aquila BioMedical offers Integrated Drug Discovery, Chemistry Services, and Biology Services.
Who are Aquila BioMedical's investors?
Aquila BioMedical has 2 investors. Key investors include European Union, and Concept Life Sciences.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.